All Articles

Curium's landmark $8 billion acquisition of Lantheus is set to create a global powerhouse in nuclear medicine, reshaping patient care and the competitive landscape.

A new defense tech player just landed a major Air Force deal. We go beyond the headlines to reveal the financial machinery and strategic plays driving it.

Enterprise AI leader Yellow.ai is going public via a SPAC merger, aiming to deploy autonomous agents and disrupt the massive $900 billion BPO industry.

As Students 2 Science founder Dr. Paul Winslow steps back, the nonprofit signals a new growth phase by promoting a proven leader from within its own ranks.

Autolus Therapeutics reports a 100% year-over-year sales jump and a stunning gross margin reversal, securing a $250M credit facility to fund its next big move.

Biocon's Yesafili, an interchangeable biosimilar to the $5.9B eye drug Eylea, launches in the US, promising major cost savings and market disruption.

As AI models multiply, 'subscription fatigue' is overwhelming users. A new service, Ask-Chat.ai, bundles 20+ top AIs, signaling a market shift toward aggregation.

With blockbuster sales for its MS drug BRIUMVI, TG Therapeutics is raising revenue targets and aggressively expanding its pipeline into new diseases.

Robinson Helicopter's new 10-seat R88 debuts in Brazil, targeting a critical gap in the market. Is this the cost-effective workhorse the region needs?

ADAMA's appointment of a top M&A lawyer as General Counsel reveals a strategy focused on global growth, innovation, and navigating a complex ag-tech landscape.

Lipocine's appointment of M&A veteran Michael Grissinger isn't just a new face on the board; it's a clear signal of a strategic pivot towards high-stakes partnerships.

The German prosthetics giant just built its first US facility from scratch. It’s more than a clinic; it's a bet on transparency, community, and the 2028 Paralympics.

Beyond its star-studded Seattle gala, the Asian Hall of Fame is pioneering a new philanthropic model focused on neurodiversity, women in tech, and legacy.

Zac Brown Band's cruise giveaway is more than a thank you; it's a blueprint for deep brand integration and a new, high-stakes era of fan engagement.

Fresh off a $260M IPO, Seaport Therapeutics is advancing a de-risked pipeline for depression and anxiety, leveraging its novel platform to unlock new potential.

The healthcare network appoints Jonathan Coggins to scale operations and Mandy Lawrence to a new CXO role, a dual strategy to accelerate growth and redefine care.

Riding a wave of strong Q2 results, Supernus announces a merger of equals with Indivior, set to create a new, scaled player in CNS and addiction medicine.

With its second major acquisition of 2026, COEO Solutions is building an IT services giant for the underserved mid-market. What does this mean for the future?

Private equity giant KKR is acquiring medical device maker Integer in a $5.7B deal, signaling a major investment in the future of outsourced MedTech innovation.

A 104-year-old firm gets new leadership. But this isn't just a handover; it's a strategic bet on tech-driven construction and market disruption.